Meeder Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $31.5K | Hold |
|
|||||
|
2024
Q4 | $32.8K | Hold |
|
|||||
|
2024
Q3 | $32.1K | Hold |
|
|||||
|
2024
Q2 | $38.7K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2K | Buy |
|
|||||
|
2022
Q2 | $1K | Buy |
|
|||||
|
2022
Q1 | $1K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $77K | Buy |
|
|||||
|
2021
Q2 | $2K | Sell |
|
|||||
|
2021
Q1 | $14K | Buy |
|
|||||
|
2020
Q4 | $0 | Sell |
|
|||||
|
2020
Q3 | $55K | Buy |
|
|||||
|
2020
Q2 | $36K | Buy |
|
|||||
|
2020
Q1 | $9K | Sell |
|
|||||
|
2019
Q4 | $173K | Buy |
|
|||||
|
2019
Q3 | $69K | Buy |
|
|||||
|
2019
Q2 | $4K | Sell |
|
|||||
|
2019
Q1 | $153K | Buy |
|
|||||
|
2018
Q4 | $211K | Sell |
|
|||||
|
2018
Q3 | $261K | Buy |
|
|||||
|
2018
Q2 | $82.2K | Buy |
|
|||||
|
2018
Q1 | $50K | Sell |
|
|||||
|
2017
Q4 | $53K | Buy |
|
|||||
|
2017
Q3 | $53K | Buy |
|
|||||
|
2017
Q2 | $18K | Buy |
|